Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Gotoh

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Arerugi = [Allergy]|September 15, 2005
[Natural airborne pollen contamination of clothes and facial skin]Minoru Okuda, Kimihiro Ohkubo, Minoru Gotoh, et al.
Arerugi = [Allergy]|July 13, 2004
[Treatment of Japanese cedar pollinosis and its impact on patient satisfaction]Minoru Okuda, Kimihiro Ohkubo, Minoru Gotoh, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 13, 2015
[A biomarker set relation to the efficacy of allergen-specific immunotherapy]Osamu Kaminuma, Minoru Gotoh, Akihiko Nakaya, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 17, 2019
[Mechanisms of allergen immunotherapy elucidated through integrated comparative analysis]Osamu Kaminuma, Minoru Gotoh, Kimihiro Okubo, et al.
Auris, Nasus, Larynx|August 27, 2016
Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trialKimihiro Okubo, Minoru Gotoh, Michinori Togawa, et al.
Expert Opinion on Pharmacotherapy|February 17, 2009
Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber)Kazuhiro Hashiguchi, Huaipeng Tang, Toshio Fujita, et al.
Arerugi = [Allergy]|August 28, 2018
[INVESTIGATION OF TREATMENT GOAL IN ALLERGEN IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS]Minoru Gotoh, Kimihiro Okubo, Yoshitaka Okamoto, et al.
Allergy and Asthma Proceedings|December 31, 2024
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in JapanMinoru Gotoh, Yuriko Maekawa, Shiori Saito, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 26, 2013
Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guidelineMinoru Gotoh, Atsushi Yuta, Mitsuhiro Okano, et al.
Journal of Drug Assessment|August 19, 2016
Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamberShuichiro Endo, Minoru Gotoh, Kimihiro Okubo, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Arerugi = [Allergy]|September 15, 2005
[Natural airborne pollen contamination of clothes and facial skin]Minoru Okuda, Kimihiro Ohkubo, Minoru Gotoh, et al.
Arerugi = [Allergy]|July 13, 2004
[Treatment of Japanese cedar pollinosis and its impact on patient satisfaction]Minoru Okuda, Kimihiro Ohkubo, Minoru Gotoh, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 13, 2015
[A biomarker set relation to the efficacy of allergen-specific immunotherapy]Osamu Kaminuma, Minoru Gotoh, Akihiko Nakaya, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 17, 2019
[Mechanisms of allergen immunotherapy elucidated through integrated comparative analysis]Osamu Kaminuma, Minoru Gotoh, Kimihiro Okubo, et al.
Auris, Nasus, Larynx|August 27, 2016
Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trialKimihiro Okubo, Minoru Gotoh, Michinori Togawa, et al.
Expert Opinion on Pharmacotherapy|February 17, 2009
Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber)Kazuhiro Hashiguchi, Huaipeng Tang, Toshio Fujita, et al.
Arerugi = [Allergy]|August 28, 2018
[INVESTIGATION OF TREATMENT GOAL IN ALLERGEN IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS]Minoru Gotoh, Kimihiro Okubo, Yoshitaka Okamoto, et al.
Allergy and Asthma Proceedings|December 31, 2024
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in JapanMinoru Gotoh, Yuriko Maekawa, Shiori Saito, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 26, 2013
Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guidelineMinoru Gotoh, Atsushi Yuta, Mitsuhiro Okano, et al.
Journal of Drug Assessment|August 19, 2016
Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamberShuichiro Endo, Minoru Gotoh, Kimihiro Okubo, et al.
Pageof 9